2040
C. J. Magesh et al. / Bioorg. Med. Chem. Lett. 14 (2004) 2035–2040
11. Lucchini, V.; Prato, M.; Scorrano, G.; Tecilla, P. J. Org.
Chem. 1988, 53, 2251–2258.
12. Atwood, D. A.; Jegier, J. A.; Rutherford, D. Inorg. Chem.
1996, 35, 63–70.
suspension in TBS was added to it. The initial OD of the
sample was recorded. The mixture was incubated for
90min at 23 ꢁC. Final OD of the mixture was
recorded. The initial OD)final OD, gives the bacteriolytic
activity.
13. General procedure for the preparation of pyranoquino-
lines: To a mixture of imine (1.1 mmol) or a mixture of
phenylglyoxal monohydrate (1.1 mmol) and aromatic
amine (1.1 mmol), dienophiles [cyclopentadiene (2.2 mmol)
or 3,4-dihydropyran (2.2 mmol) or dihydrofuran
(2.2 mmol)] in dry acetonitrile (5 mL) salen–AlCl complex
(0.22 mmol) was added and stirred at room temperature
for appropriate times. To the reaction mixture water was
added (25 mL) and extracted with CHCl3 (4 · 10mL),
washed with brine and dried over anhydrous Na2SO4,
filtered and the solvent evaporated. The residue was
purified by column chromatography with petroleum ether/
ethyl acetate to afford the cycloadducts.
14. Procedure for bactericidal activity: The test compound
(20mg) was dissolved in 500 lL of DMSO. Five microli-
tres (0.2 mg approx) of the stock solution was taken and
95 lL bacterial suspension in Tris buffer saline (0.8 OD at
580nm) was added to it. The mixture was incubated at
14 ꢁC for 14 h. After incubation, it was subjected to plating
in TCBS agar (Thiosulphate, Citric, Bile salt, sucrose
agar). After 12 h, the culture plate was observed for
bacterial growth.
16. All the compounds were characterized by FT-IR, NMR
(500 MHz), MS and CHN analysis. The spectroscopic
data were fully consistent with the assigned structures.
Selected spectroscopic data: Pyran adduct (6) FT-IR
(KBr): 3380, 3325, 2940, 1603, 1484, 1074 cmÀ1
;
1H
NMR d (500 MHz, CDCl3): 7.47–7.39 (m, 5H), 7.34 (t,
1H, J ¼ 6:8 Hz), 7.1 (t, 1H, J ¼ 8:0Hz), 6.82 (t, 1H,
J ¼ 7:4 Hz), 6.6 (d, 1H, J ¼ 6:8 Hz), 5.35 (d, 1H, J ¼
5:75 Hz), 4.7 (d, 1H, J ¼ 2:2 Hz), 3.9 (br s, 1H, NH), 3.62
(d, 1H, J ¼ 11:4 Hz), 3.4 (m, 1H), 2.21–2.16 (m, 1H), 1.62–
13
1.30(m, 4H);
C NMR d (75 MHz, CDCl3): 145.3,
141.26, 128.5, 128.2, 127.7, 127.6, 126.9, 120.0, 118.4,
114.5, 72.8, 60.7, 59.4, 39.0, 25.5, 18.1; MS m=z 265 (Mþ);
Anal. Calcd for C18H19NO: C, 81.48; H, 7.22; N, 5.28.
Found: C, 81.36; H, 7.21; N, 5.26. Pyran adduct (7) FT-IR
(KBr): 3368, 3026, 2936, 1610, 1489, 1073 cmÀ1; 1H NMR
d (500 MHz, CDCl3): 7.45–7.33 (m, 5H), 7.26 (d, 1H,
J ¼ 6:8 Hz), 7.11 (t, 1H, J ¼ 8:0Hz), 6.73 (t, 1H, J ¼
6:9 Hz), 6.54 (d, 1H, J ¼ 8:0Hz), 4.74 (d, 1H, J ¼
10:85 Hz), 4.42 (d, 1H, J ¼ 2:8 Hz), 4.10(m, 2H), 3.75 (t,
1H, J ¼ 11:45 Hz), 2.11 (m, 1H), 1.88 (m, 1H), 1.71–1.30
(m, 3H); 13C NMR d (75 MHz, CDCl3): 144.8, 142.4,
131.0, 129.4, 128.7, 128.0, 127.9, 120.7, 117.5, 114.2, 74.6,
68.7, 54.9, 39.0, 24.2, 22.1; MS m=z 265 (Mþ); Anal. Calcd
for C18H19NO: C, 81.48; H, 7.22; N, 5.28. Found: C,
81.45; H, 7.23; N, 5.25.
15. Procedure for bacteriolytic activity: Bacterial suspension
in TBS was prepared with an optical density of 0.8 OD at
580nm (double beam UV spectrometer). TBS (Tris buffer
saline) served as the blank. The test compound (10mg)
was dissolved in 150L of DMSO and 2850 lL of bacterial